Goldman Sachs delays return to office for U.S. workers
Reuters
Published Jan 13, 2022 09:35AM ET
Updated Jan 13, 2022 10:31AM ET
(Reuters) - Goldman Sachs Group Inc (NYSE:GS) has postponed its return-to-office plan for U.S. staff by another two weeks as COVID-19 cases in the country flare up, largely fueled by the highly contagious Omicron coronavirus variant.
The bank's employees were told they could delay returning to office to Feb. 1, a spokesperson said, after having previously allowed workers to work from home until Jan. 18.
Goldman, which had been one of the most aggressive banks in bringing staff back into offices, has been forced to alter plans because of the fast-spreading Omicron variant of the coronavirus.
The plans were first reported by Bloomberg News.
The bank has also mandated vaccines and booster shots for eligible employees, effective Feb. 1.
Big Wall Street firms continue to grapple with how to bring workers back to offices safely, with coronavirus cases rising rapidly again.
Citigroup Inc (NYSE:C) said last week U.S. employees who have not been vaccinated against COVID-19 by Jan. 14 will be placed on unpaid leave and fired at the end of the month unless they are granted an exemption and accommodation.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.